Diagnostic Partnering and Deals to Augur Well Throughout the Forecast Period
Diagnostic deals associated with Alzheimer's disease and contagious disease, namely Zika virus have signified the importance of diagnostic partnering in oncology. In 2017, genetic technology became the kingpin for the oncology diagnostic related acquisition. In a bid to strengthen its health care offerings through expansion, a deal partly funded by Japan's public/private Innovation Network Corporation witnessed Konica Minolta Inc. agreeing to pay USD 800 million in cash along with up to USD 200 million in earn-outs for Ambry Genetic Corp.,...
View full press release